SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- US stock futures tumble as Trump says Iran deal is 'over', oil climbs
- Oil jumps over 6% to two-week high after Trump says deal with Iran 'over'
- Citi says SpaceX stock has path to $900+ valuation. Here’s how
- Tesla stock target lifted at RBC on potential SpaceX merger
- Short squeezes more likely than widespread selling: Citi
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
SOPHiA GENETICS SA (SOPH) Tops Q2 EPS by 8c
August 9, 2022 7:12 AM EDTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.31), $0.08 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.15 million.
For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.
... More